Rigel Pharma (RIGL) Tops Q4 EPS by 80c
Get Alerts RIGL Hot Sheet
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q4 EPS of $0.80. Revenue for the quarter came in at $57.6 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ManpowerGroup (MAN) Tops Q2 EPS by 4c; offers guidance
- Ollie's Bargain Outlet (OLLI) PT Lowered to $98 at KeyBanc
- Equity Bancshares (EQBK) PT Raised to $54 at Keefe, Bruyette & Woods
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share